title: Idarucizumab for dabigatran overdose in a child.
authors.affiliation: Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Foundation Trust, Oxford Comprehensive Biomedical Resource Centre*, Oxford, UK.
authors.forename: Susan
authors.initials: S
authors.lastname: Shapiro
authors.affiliation: Department of Paediatric Haematology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
authors.forename: Neha
authors.initials: N
authors.lastname: Bhatnagar
authors.affiliation: Department of Haematology, Royal Berkshire Hospital, Reading, UK.
authors.forename: Asif
authors.initials: A
authors.lastname: Khan
authors.affiliation: Haemostasis Laboratory, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
authors.forename: James
authors.initials: J
authors.lastname: Beavis
authors.affiliation: Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Foundation Trust, Oxford Comprehensive Biomedical Resource Centre*, Oxford, UK.
authors.forename: David
authors.identifier: 0000-0001-6779-6566
authors.initials: D
authors.lastname: Keeling
mesh_terms: D000293:Adolescent; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology / Q000627:therapeutic use*; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D000991:Antithrombins / Q000008:administration & dosage / Q000009:adverse effects*; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D000069604:Dabigatran / Q000008:administration & dosage / Q000009:adverse effects* / Q000037:antagonists & inhibitors*; D062787:Drug Overdose / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D000991:Antithrombins; C000594745:idarucizumab; D000069604:Dabigatran
keywords: dabigatran; direct oral anticoagulant; idarucizumab; overdose; reversal